Article
Using the canine microbiome to bridge translation of cancer immunotherapy from pre-clinical murine models to human clinical trials
12 Aug 2022
Abstract excerpt
The microbiome has clearly been established as a cutting-edge field in tumor immunology and immunotherapy. Growing evidence supports the role of the microbiome in immune surveillance, self-tolerance, and response to immune checkpoint inhibitors such as anti PD-L1 and CTLA-4 blockade (1-6). Moreover, recent studies including those using fecal microbial transplantation (FMT) have demonstrated that response to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
